Body Composition Analysis in Patients Undergoing Chemoembolization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

21 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatocellular carcinoma represents 80-90% of primary hepatic malignant tumors. 80% of patients with hepatocellular carcinoma are associated with cirrhosis.

Chemoembolization is a process in which a chemotherapeutic agent is deposited directly into the hepatic tumor where the principal artery is embolized.

Bioelectrical impedance bases its evaluation in a model where the body is conformed by two different compartments: fat mass and fat free mass.

Bioelectrical impedance is complemented by vectorial analysis, which is independent to the state of hydration and is helpful to monitor any changes in corporal composition. It can be used as a control for the interpretation of the bioelectrical impedance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation

NCT01744639

Liver Carcinoma

WITHDRAWN NA

Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients

NCT01798173

Cirrhosis With Hepatocellular Carcinoma Cirrhosis Without Hepatocellular Carcinoma

COMPLETED NA

Liquid Biopsy in Hepatocellular Carcinoma

NCT04111029

Hepatic Carcinoma Malignant Primary Non-Resectable

UNKNOWN

Liver and Biliary Tumor Tissue Registry

NCT02917759

Hepatocellular Carcinoma Cholangiocarcinoma

TERMINATED

Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation

NCT02023190

Liver Cirrhosis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocellular Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hepato-renal disease
* Patients with hepatocellular carcinoma that are put down to radiofrequency ablation
* Patients with depression or any psiquiatric disease.
* Patients that don't agree to participate in the project.

Exclusion Criteria

* Patients with hepatocellular carcinoma that are put down to radiofrequency ablation
* Patients with depression or any psiquiatric disease.
* Patients that don't agree to participate in the project.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No